[Liebert] The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer

Marilena Post time 2024-3-27 18:41:34 | Show all posts |Read mode
Reward10points

journal£ºCancer Biotherapy and Radiopharmaceuticals

Authors£ºRuoyang Li; Xuewei Zhao; Yunfei Huang; Chunxiao Li; Lei Liu; Meiqi Wang; Jiaxing Wang; Zhenchuan Song

Published date£º--

DOI£º10.1089/cbr.2024.0011

PDF link£ºhttps://www.liebertpub.com/doi/full-xml/10.1089/cbr.2024.0011

Article link£ºhttp://dx.doi.org/10.1089/cbr.2024.0011

Article Source£ºMary Ann Liebert Inc¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
David Post time 2024-3-27 18:41:35 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    50

Latest Reply

Return to the list